Global genetic deletion of NOX4 and the dual pharmacological inhibitor of NOX1/NOX4 GKT137831 attenuate H2O2 generation, Ang II-induced myofibroblast proliferation and migration, and the severity of Ang II-induced HTN [294,298]. Here, NOX4 is linked to hypertensive disorder.